SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.
Condition: Breast Cancer Intervention: Drug: SHR6390+anatrozole Sponsors: Tianjin Medical University Cancer Institute and Hospital; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2021 Category: Research Source Type: clinical trials